P2Y receptors and atherosclerosis in apolipoprotein E-deficient mice

被引:37
|
作者
Guns, Pieter-Jan D. F. [1 ]
Hendrickx, Jan [1 ]
Van Assche, Tim [1 ]
Fransen, Paul [1 ]
Bult, Hidde [1 ]
机构
[1] Univ Antwerp, CDE, Div Pharmacol, B-2610 Antwerp, Belgium
关键词
atherosclerosis; apoE; P2Y(6); P2Y(2); gene expression; macrophage; suramin; PPADS; SMOOTH-MUSCLE-CELLS; DOUBLE-KNOCKOUT MICE; ENDOTHELIAL-CELLS; NUCLEOTIDE RECEPTORS; EXPRESSION; SURAMIN; GROWTH; MOUSE; UDP; LIPOPOLYSACCHARIDE;
D O I
10.1111/j.1476-5381.2009.00497.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: P2Y nucleotide receptors are involved in the regulation of vascular tone, smooth muscle cell (SMC) proliferation and inflammatory responses. The present study investigated whether they are involved in atherosclerosis. Experimental approach: mRNA of P2Y receptors was quantified (RT-PCR) in atherosclerotic and plaque-free aorta segments of apolipoprotein E-deficient (apoE(-/-)) mice. Macrophage activation was assessed in J774 macrophages, and effects of non-selective purinoceptor antagonists on atherosclerosis were evaluated in cholesterol-fed apoE(-/-) mice. Key results: P2Y(6) receptor mRNA was consistently elevated in segments with atherosclerosis, whereas P2Y(2) receptor expression remained unchanged. Expression of P2Y(1) or P2Y(4) receptor mRNA was low or undetectable, and not influenced by atherosclerosis. P2Y(6) mRNA expression was higher in cultured J774 macrophages than in cultured aortic SMCs. Furthermore, immunohistochemical staining of plaques demonstrated P2Y(6)-positive macrophages, but few SMCs, suggesting that macrophage recruitment accounted for the increase in P2Y(6) receptor mRNA during atherosclerosis. In contrast to ATP, the P2Y(6)-selective agonist UDP increased mRNA expression and activity of inducible nitric oxide synthase and interleukin-6 in J774 macrophages; this effect was blocked by suramin (100-300 mu M) or pyridoxal-phosphate-6-azophenyl-2'-4'-disulphonic acid (PPADS, 10-30 mu M). Finally, 4-week treatment of cholesterol-fed apoE(-/-) mice with suramin or PPADS (50 and 25 mg.kg(-1).day(-1) respectively) reduced plaque size, without changing plaque composition (relative SMC and macrophage content) or cell replication. Conclusions and implications: These results suggest involvement of nucleotide receptors, particularly P2Y(6) receptors, during atherosclerosis, and warrant further research with selective purinoceptor antagonists or P2Y(6) receptor-deficient mice. British Journal of Pharmacology (2010) 159, 326-336; doi: 10.1111/j.1476-5381.2009.00497.x; published online 24 December 2009
引用
收藏
页码:326 / 336
页数:11
相关论文
共 50 条
  • [1] Roles of Purinergic Receptor P2Y, G Protein-Coupled 12 in the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice
    Li, Ding
    Wang, Yanhua
    Zhang, Lin
    Luo, Xinping
    Li, Jian
    Chen, Xuejin
    Niu, Haixia
    Wang, Kemin
    Sun, Yueping
    Wang, Xuefeng
    Yan, Yan
    Chai, Weiran
    Gartner, T. Kent
    Liu, Junling
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (08) : E81 - U104
  • [2] Peroxiredoxin 2 Deficiency Exacerbates Atherosclerosis in Apolipoprotein E-Deficient Mice
    Park, Jong-Gil
    Yoo, Ji-Young
    Jeong, Se-Jin
    Choi, Jae-Hoon
    Lee, Mi-Ran
    Lee, Mi-Ni
    Lee, Jeong Hwa
    Kim, Hyoung Chin
    Jo, Hanjoong
    Yu, Dae-Yeul
    Kang, Sang Won
    Rhee, Sue Goo
    Lee, Mun-Han
    Oh, Goo Taeg
    CIRCULATION RESEARCH, 2011, 109 (07) : 739 - U80
  • [3] Diet and Atherosclerosis in Apolipoprotein E-Deficient Mice
    Imaizumi, Katsumi
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2011, 75 (06) : 1023 - 1035
  • [4] Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice
    Nigro, Patrizia
    Satoh, Kimio
    O'Dell, Michael R.
    Soe, Nwe Nwe
    Cui, Zhaoqiang
    Mohan, Amy
    Abe, Jun-ichi
    Alexis, Jeffrey D.
    Sparks, Janet D.
    Berk, Bradford C.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 208 (01) : 53 - 66
  • [5] Activation of VPAC1 receptors aggravates early atherosclerosis in hypercholesterolemic apolipoprotein E-deficient mice
    Sheikine, Yuri
    Deodato, Barbara
    Olofsson, Peder S.
    Soderstrom, Leif A.
    Lundberg, Anna M.
    Bodin, Inger
    Rudling, Mats
    Theodorsson, Elvar
    Hansson, Goran K.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 402 (03) : 471 - 476
  • [6] Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice
    Yu, Jie
    Deng, Mengyang
    Zhao, Jinghong
    Huang, Lan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 391 (01) : 261 - 266
  • [7] Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice
    Okamoto, Y
    Kihara, S
    Ouchi, N
    Nishida, M
    Arita, Y
    Kumada, M
    Ohashi, K
    Sakai, N
    Shimomura, I
    Kobayashi, H
    Terasaka, N
    Inaba, T
    Funahashi, T
    Matsuzawa, Y
    CIRCULATION, 2002, 106 (22) : 2767 - 2770
  • [8] Inulin attenuates atherosclerosis in apolipoprotein E-deficient mice
    Rault-Nania, Marie-Helene
    Gueux, Elyett
    Demougeot, Celine
    Demigne, Christian
    Rock, Edmond
    Mazur, Andrzej
    BRITISH JOURNAL OF NUTRITION, 2006, 96 (05) : 840 - 844
  • [9] Effect of Dehydroepiandrosterone on Atherosclerosis in Apolipoprotein E-Deficient Mice
    Yamakawa, Tadashi
    Ogihara, Kikumi
    Nakamura, Misa
    Utsunomiya, Hirotoshi
    Kadonosono, Kazuaki
    Kishikawa, Seigo
    Terauchi, Yasuo
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2009, 16 (04) : 501 - 508
  • [10] Absence of Interferon Regulatory Factor 1 Protects Against Atherosclerosis in Apolipoprotein E-Deficient Mice
    Du, Meng
    Wang, Xiaojing
    Mao, Xiaoxiang
    Yang, Liu
    Huang, Kun
    Zhang, Fengxiao
    Wang, Yan
    Luo, Xi
    Wang, Cheng
    Peng, Jiangtong
    Liang, Minglu
    Huang, Dan
    Huang, Kai
    THERANOSTICS, 2019, 9 (16): : 4688 - 4703